Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

A comparative evaluation of the publications of French public teaching hospitals from 2004 to 2014.

Blanc E, Boulieu R, Bertram D.

Bull Cancer. 2019 Nov 20. pii: S0007-4551(19)30371-6. doi: 10.1016/j.bulcan.2019.09.007. [Epub ahead of print]

PMID:
31759512
2.

Bibliometrics and French healthcare institutions from 2004 to 2014.

Blanc E, Boulieu R, Bertram D.

Bull Cancer. 2019 Mar;106(3):226-236. doi: 10.1016/j.bulcan.2018.10.006. Epub 2018 Dec 1.

PMID:
30509682
3.

Red Blood cell IMPDH activity in adults and children with or without azathioprine: Relationship between thiopurine metabolites, ITPA and TPMT activities.

Citterio-Quentin A, El Mahmoudi A, Perret T, Conway A, Ryan A, Beringer A, Lachaux A, Boulieu R.

Basic Clin Pharmacol Toxicol. 2019 May;124(5):600-606. doi: 10.1111/bcpt.13176. Epub 2018 Dec 28.

PMID:
30451390
4.

ITPA Activity in Children Treated by Azathioprine: Relationship to the Occurrence of Adverse Drug Reactions and Inflammatory Response.

Citterio-Quentin A, Moulsma M, Gustin MP, Lachaux A, Boulieu R.

Basic Clin Pharmacol Toxicol. 2018 Jun;122(6):588-595. doi: 10.1111/bcpt.12958. Epub 2018 Feb 26.

5.

ITPA Activity in Adults and Children Treated With or Without Azathioprine: Relationship Between TPMT Activity, Thiopurine Metabolites, and Co-medications.

Citterio-Quentin A, Moulsma M, Gustin MP, Boulieu R.

Ther Drug Monit. 2017 Oct;39(5):483-491. doi: 10.1097/FTD.0000000000000430.

PMID:
28650902
6.

Determination of inosine 5'-monophosphate dehydrogenase activity in red blood cells of thiopurine-treated patients using HPLC.

Beringer A, Citterio-Quentin A, Otero RO, Gustin C, Clarke R, Salvi JP, Boulieu R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Feb 15;1044-1045:194-199. doi: 10.1016/j.jchromb.2017.01.006. Epub 2017 Jan 10.

PMID:
28110955
7.

[Identification of knowledge deficits of pharmacy students at the beginning of the fifth year of pharmacy practice experience: Proposals to change the content of academic programs].

Charpiat B, Derfoufi S, Larger M, Janoly-Dumenil A, Mouchoux C, Allenet B, Tod M, Grassin J, Boulieu R, Catala O, Bedouch P, Goudable J, Vinciguerra C.

Ann Pharm Fr. 2016 Sep;74(5):404-12. doi: 10.1016/j.pharma.2016.01.001. Epub 2016 Mar 2. French.

PMID:
26944892
8.

Ex-Vivo percutaneous absorption of enrofloxacin: Comparison of LMOG organogel vs. pentravan cream.

Kirilov P, Tran VH, Ducrotté-Tassel A, Salvi JP, Perrot S, Haftek M, Boulieu R, Pirot F.

Int J Pharm. 2016 Feb 10;498(1-2):170-7. doi: 10.1016/j.ijpharm.2015.12.018. Epub 2015 Dec 11.

PMID:
26688043
9.

Determination of inosine triphosphate pyrophosphatase in red blood cells using HPLC: an improved method.

Citterio-Quentin A, Long S, Salvi JP, Moulsma M, Boulieu R.

Ther Drug Monit. 2014 Oct;36(5):689-91. doi: 10.1097/FTD.0000000000000075. No abstract available.

PMID:
24713866
10.

Exploring associations of 6-thioguanine nucleotide levels and other predictive factors with therapeutic response to azathioprine in pediatric patients with IBD using multilevel analysis.

Nguyen TV, Vu DH, Nguyen TM, Lachaux A, Boulieu R.

Inflamm Bowel Dis. 2013 Oct;19(11):2404-10. doi: 10.1097/MIB.0b013e3182a508c6.

PMID:
24013359
11.

[Cooperation between general practitioners and pharmacists: a systematic review].

Michot P, Catala O, Supper I, Boulieu R, Zerbib Y, Colin C, Letrilliart L.

Sante Publique. 2013 May-Jun;25(3):331-41. Review. French.

PMID:
24007909
12.

Usefulness of thiopurine metabolites in predicting azathioprine resistance in pediatric IBD patients.

Nguyen TV, Nguyen TM, Lachaux A, Boulieu R.

J Clin Pharmacol. 2013 Sep;53(9):900-8. doi: 10.1002/jcph.134. Epub 2013 Jul 15.

PMID:
23856979
13.

Relationship between azathioprine dosage and thiopurine metabolites in pediatric IBD patients: identification of covariables using multilevel analysis.

Nguyen TV, Vu DH, Nguyen TM, Lachaux A, Boulieu R.

Ther Drug Monit. 2013 Apr;35(2):251-7. doi: 10.1097/FTD.0b013e318282c3a6.

PMID:
23503453
14.

Effects of mutations on herpes simplex virus 1 thymidine kinase functionality: an in vitro assay based on detection of monophosphate forms of acyclovir and thymidine using HPLC/DAD.

Malartre N, Boulieu R, Falah N, Cortay JC, Lina B, Morfin F, Frobert E.

Antiviral Res. 2012 Sep;95(3):224-8. doi: 10.1016/j.antiviral.2012.07.001. Epub 2012 Jul 14.

PMID:
22796575
15.

Determination of inosine triphosphate pyrophosphatase phenotype in human red blood cells using HPLC.

Citterio-Quentin A, Salvi JP, Boulieu R.

Ther Drug Monit. 2012 Aug;34(4):477-80. doi: 10.1097/FTD.0b013e31825c2703.

PMID:
22673202
16.

[Therapeutic drug monitoring of 6-thioguanine nucleotides in inflammatory bowel disease: interest and limits].

Jourdil N, Fonrose X, Boulieu R, Stanke-Labesque F; Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.

Therapie. 2010 May-Jun;65(3):177-86. doi: 10.2515/therapie/2010030. Epub 2010 Aug 11. Review. French.

PMID:
20699068
17.

Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis.

Nguyen TM, Daubard M, Le Gall C, Larger M, Lachaux A, Boulieu R.

Ther Drug Monit. 2010 Aug;32(4):433-7. doi: 10.1097/FTD.0b013e3181dbd712.

PMID:
20479703
18.

Suivi thérapeutique pharmacologique des 6-thioguanine nucléotides dans les maladies inflammatoires cryptogéniques de l'intestin : intérêt et limites.

Jourdil N, Fonrose X, Boulieu R, Stanke-Labesque F; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.

Therapie. 2010 May-Jun;65(3):177-86. doi: 10.2515/therapie/2010030. French.

PMID:
27392984
19.
20.

Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics.

Parant F, Rivet C, Boulieu R, Gagnieu MC, Dumortier J, Boillot O, Lachaux A.

Ther Drug Monit. 2009 Dec;31(6):727-33. doi: 10.1097/FTD.0b013e3181c01d07.

PMID:
19881404
21.

Evaluation of MPA and MPAG removal by continuous venovenous hemodiafiltration and continuous venovenous hemofiltration.

Cussonneau X, Bolon-Larger M, Prunet-Spano C, Bastien O, Boulieu R.

Ther Drug Monit. 2008 Feb;30(1):100-2. doi: 10.1097/FTD.0b013e3181633667.

PMID:
18223470
22.

Pharmacokinetic-pharmacodynamic modelling of ketamine in six neurotraumatised intensive care patients.

Hijazi Y, Bodonian C, Salord F, Bressolle F, Boulieu R.

Clin Drug Investig. 2003;23(9):605-9. No abstract available.

PMID:
17535074
23.

Relationship between MPA free fraction and free MPAG concentrations in heart transplant recipients based on simultaneous HPLC quantification of the target compounds in human plasma.

Cussonneau X, Bolon-Larger M, Prunet-Spano C, Bastien O, Boulieu R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):674-8. Epub 2007 Feb 28.

PMID:
17350903
24.

A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.

Bolon-Larger M, Chamouard V, Bressolle F, Boulieu R.

Ther Drug Monit. 2007 Feb;29(1):20-6.

PMID:
17304146
25.

A rapid and simple HPLC method for the analysis of propofol in biological fluids.

Cussonneau X, De Smet E, Lantsoght K, Salvi JP, Bolon-Larger M, Boulieu R.

J Pharm Biomed Anal. 2007 Jul 27;44(3):680-2. Epub 2006 Nov 28.

PMID:
17129698
26.

Adsorption of mycophenolic acid and its phenolic glucuronide to glass, polystyrene, and polypropylene containers.

Cussonneau X, Bolon-Larger M, Boulieu R.

Clin Chem. 2006 May;52(5):904-6. No abstract available.

27.

Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.

Loichot C, Bentue-Ferrer D, Bernard N, Bonardet A, Boulieu R, Kergueris MF, Paintaud G, Peytavin G, Simon N, Marquet P; Therapeutic Drug Monitoring Group of the French Pharmacological Society.

Fundam Clin Pharmacol. 2006 Feb;20(1):91-6.

PMID:
16448399
28.
29.

HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material.

Bolon M, Jeanpierre L, El Barkil M, Chelbi K, Sauviat M, Boulieu R.

J Pharm Biomed Anal. 2004 Nov 15;36(3):649-51. Erratum in: J Pharm Biomed Anal. 2005 Apr 29;37(5):1185.

PMID:
15522544
31.

Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury.

Hijazi Y, Bodonian C, Bolon M, Salord F, Boulieu R.

Br J Anaesth. 2003 Feb;90(2):155-60.

32.

[Use of midazolam in postoperative sedation of patients with multiple organ failure treated with hemodiafiltration. Clinical study and pharmacokinetics].

Bastien O, Bolon M, Flamens C, Lehot JJ, Boulieu R.

Ann Fr Anesth Reanim. 2002 Nov;21(9):692-7. French.

PMID:
12494801
33.

Solid-phase microextraction of human plasma samples for determination of sufentanil by gas chromatography-mass spectrometry.

Paradis C, Dufresne C, Bolon M, Boulieu R.

Ther Drug Monit. 2002 Dec;24(6):768-74.

PMID:
12451295
34.

[Sedation induced by midazolam in intensive care: pharmacologic and pharmacokinetic aspects].

Bolon M, Boulieu R, Flamens C, Paulus S, Bastien O.

Ann Fr Anesth Reanim. 2002 Jun;21(6):478-92. Review. French.

PMID:
12134593
35.

Propofol metabolites in man following propofol induction and maintenance.

Favetta P, Degoute CS, Perdrix JP, Dufresne C, Boulieu R, Guitton J.

Br J Anaesth. 2002 May;88(5):653-8.

36.
37.

Protein binding of ketamine and its active metabolites to human serum.

Hijazi Y, Boulieu R.

Eur J Clin Pharmacol. 2002 Apr;58(1):37-40. Epub 2002 Mar 12.

PMID:
11956671
38.

Development of an in vitro screening model for the biosynthesis of acyl glucuronide metabolites and the assessment of their reactivity toward human serum albumin.

Bolze S, Bromet N, Gay-Feutry C, Massiere F, Boulieu R, Hulot T.

Drug Metab Dispos. 2002 Apr;30(4):404-13.

PMID:
11901094
39.

Methylated and non methylated thiopurine nucleotide ratio (Me6-MPN/6-TGN): usefulness in the monitoring of azathioprine therapy?

Boulieu R, Dervieux T, Gallant I, Sauviat M, Bertocchi M, Mornex JF.

Adv Exp Med Biol. 2000;486:361-7. No abstract available.

PMID:
11783516
40.

Stability of sufentanil in human plasma samples.

Dufresne C, Favetta P, Paradis C, Boulieu R.

Ther Drug Monit. 2001 Oct;23(5):550-2.

PMID:
11591902
41.

Midazolam disposition in patients undergoing continuous venovenous hemodialysis.

Bolon M, Bastien O, Flamens C, Paulus S, Boulieu R.

J Clin Pharmacol. 2001 Sep;41(9):959-62.

PMID:
11549100
42.

Stability of ketamine and its metabolites norketamine and dehydronorketamine in human biological samples.

Hijazi Y, Bolon M, Boulieu R.

Clin Chem. 2001 Sep;47(9):1713-5. No abstract available.

43.

Phenotype determination of thiopurine methyltransferase in erythrocytes by HPLC.

Boulieu R, Sauviat M, Dervieux T, Bertocchi M, Mornex JF.

Clin Chem. 2001 May;47(5):956-8. No abstract available.

45.

Prolonged sedation due to an accumulation of midazolam in an intensive care patient with hypothyroidism.

Bolon M, Bastien O, Flamens C, Boulieu R.

Eur J Clin Pharmacol. 2000 Dec;56(9-10):771-2. No abstract available.

PMID:
11214791
46.

Detection of new propofol metabolites in human urine using gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry techniques.

Favetta P, Dufresne C, Désage M, Païssé O, Perdrix JP, Boulieu R, Guitton J.

Rapid Commun Mass Spectrom. 2000;14(20):1932-6.

PMID:
11013422
47.

High-performance liquid chromatographic assay to detect hydroxylate and conjugate metabolites of propofol in human urine.

Favetta P, Guitton J, Degoute CS, Van Daele L, Boulieu R.

J Chromatogr B Biomed Sci Appl. 2000 May 26;742(1):25-35.

PMID:
10892581
48.

Pyrolysis-gas-liquid chromatography with atomic emission detection for the identification of Corynebacterium species.

Voisin S, Renaud FN, Freney J, de Montclos M, Boulieu R, Deruaz D.

J Chromatogr A. 1999 Nov 26;863(2):243-8.

PMID:
10593504
49.

Implementation of a quality system in a therapeutic drug monitoring laboratory.

Gaillard-France S, Boulieu R.

Therapie. 1999 May-Jun;54(3):315-20.

PMID:
10500444
50.

Supplemental Content

Loading ...
Support Center